A Randomized Phase II Trial of Pemetrexed or Pemetrexed/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
Not Applicable
Recruiting
- Conditions
- on-squamous Non-small cell lung cancer
- Registration Number
- JPRN-UMIN000006912
- Lead Sponsor
- Hokuriku Thoracic Oncology Group
- Brief Summary
patients are recruiting.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1)Interstitial pneumonia or pulmonary fibrosis on chest X-ray 2) brain metastasis 3) history of hemoptysis 4) history or complications of obvious diverticulitis 5) cavitary lesions 1cm or more 6) serious complications 7) pleural effusion, ascitis drainage is necessary for, and pericardial effusion 8) active multiple primary cancer 9) pregnancy, lactation, or, intention to pregnancy 10) a history of serious drug hypersensitivity 11) patients whom it is judged to have difficulty in participation in study because of psychosis or neurologic disease 12) The case that is judged to be inadequacy for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method